Molecular	JJ	molecular JJ PennPOS
targets	NNS	target NNS PennPOS
in	IN	in IN PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
:	:	: : NUPOS
the	DT	the dt NUPOS
myofibroblast	NN	myofibroblast NN PennPOS
in	IN	in IN PennPOS
focus	NN	focus NN PennPOS
.	.	. . NUPOS

Idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
is	VBZ	be vbz NUPOS
one	CD	one crd NUPOS
of	IN	of pp-f NUPOS
a	DT	a dt NUPOS
group	NN	group NN PennPOS
of	IN	of pp-f NUPOS
interstitial	JJ	interstitial JJ PennPOS
lung	NN	lung NN PennPOS
diseases	NNS	disease NNS PennPOS
that	WDT	that WDT PennPOS
are	VBP	be vbb NUPOS
characterized	VBN	characterize VBN PennPOS
by	IN	by IN PennPOS
excessive	JJ	excessive JJ PennPOS
matrix	NN	matrix NN PennPOS
deposition	NN	deposition NN PennPOS
and	CC	and cc NUPOS
destruction	NN	destruction NN PennPOS
of	IN	of pp-f NUPOS
the	DT	the dt NUPOS
normal	JJ	normal JJ PennPOS
lung	NN	lung NN PennPOS
architecture	NN	architecture NN PennPOS
.	.	. . NUPOS

Long-term	JJ	long-term JJ PennPOS
survival	NN	survival NN PennPOS
of	IN	of pp-f NUPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
is	VBZ	be vbz NUPOS
poor	JJ	poor JJ PennPOS
,	,	, , NUPOS
with	IN	with pp NUPOS
a	DT	a dt NUPOS
5-year	JJ	5-year JJ PennPOS
survival	NN	survival NN PennPOS
rate	NN	rate NN PennPOS
of	IN	of pp-f NUPOS
only	RB	only av-j NUPOS
20	CD	20 crd NUPOS
%	NN	% NN PennPOS
.	.	. . NUPOS

Despite	IN	despite pp NUPOS
a	DT	a dt NUPOS
lack	NN	lack NN PennPOS
of	IN	of pp-f NUPOS
evidence-based	JJ	evidence-based JJ PennPOS
benefit	NN	benefit NN PennPOS
,	,	, , NUPOS
IPF	NN	IPF NN PennPOS
has	VBZ	have vdz NUPOS
historically	RB	historically av-j NUPOS
been	VBN	be vbn NUPOS
treated	VBN	treat VBN PennPOS
with	IN	with pp NUPOS
corticosteroids	NNS	corticosteroid NNS PennPOS
and/or	CC	and/or CC PennPOS
cytotoxic	JJ	cytotoxic JJ PennPOS
agents	NNS	agent NNS PennPOS
such	JJ	such JJ PennPOS
as	IN	as c-acp NUPOS
prednisone	NN	prednisone NN PennPOS
.	.	. . NUPOS

Given	VBN	give VBN PennPOS
the	DT	the dt NUPOS
poor	JJ	poor JJ PennPOS
efficacy	NN	efficacy NN PennPOS
of	IN	of pp-f NUPOS
these	DT	these d NUPOS
drugs	NNS	drug NNS PennPOS
,	,	, , NUPOS
novel	JJ	novel JJ PennPOS
therapeutic	JJ	therapeutic JJ PennPOS
strategies	NNS	strategy NNS PennPOS
are	VBP	be vbb NUPOS
required	VBN	require VBN PennPOS
for	IN	for c-acp NUPOS
the	DT	the dt NUPOS
management	NN	management NN PennPOS
of	IN	of pp-f NUPOS
IPF	NN	IPF NN PennPOS
.	.	. . NUPOS

This	DT	this d NUPOS
demands	VBZ	demand VBZ PennPOS
a	DT	a dt NUPOS
better	JJR	good jc NUPOS
understanding	NN	understanding NN PennPOS
of	IN	of pp-f NUPOS
the	DT	the dt NUPOS
molecular	JJ	molecular JJ PennPOS
mechanisms	NNS	mechanism NNS PennPOS
underlying	VBG	underlie VBG PennPOS
the	DT	the dt NUPOS
pathogenesis	NN	pathogenesis NN PennPOS
and	CC	and cc NUPOS
progression	NN	progression NN PennPOS
of	IN	of pp-f NUPOS
this	DT	this d NUPOS
disease	NN	disease NN PennPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
primary	JJ	primary JJ PennPOS
effector	NN	effector NN PennPOS
cell	NN	cell NN PennPOS
in	IN	in IN PennPOS
fibrosis	NN	fibrosis NN PennPOS
is	VBZ	be vbz NUPOS
the	DT	the dt NUPOS
myofibroblast	NN	myofibroblast NN PennPOS
;	:	; : NUPOS
these	DT	these d NUPOS
cells	NNS	cell NNS PennPOS
are	VBP	be vbb NUPOS
highly	RB	high av-j NUPOS
synthetic	JJ	synthetic JJ PennPOS
for	IN	for c-acp NUPOS
collagen	NN	collagen NN PennPOS
,	,	, , NUPOS
have	VBP	have vhb NUPOS
a	DT	a dt NUPOS
contractile	JJ	contractile JJ PennPOS
phenotype	NN	phenotype NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
are	VBP	be vbb NUPOS
characterized	VBN	characterize VBN PennPOS
by	IN	by IN PennPOS
the	DT	the dt NUPOS
presence	NN	presence NN PennPOS
of	IN	of pp-f NUPOS
alpha-smooth-muscle-actin	JJ	alpha-smooth-muscle-actin JJ PennPOS
stress	NN	stress NN PennPOS
fibers	NNS	fiber NNS PennPOS
.	.	. . NUPOS

They	PRP	they pns31 NUPOS
may	MD	may vmb NUPOS
be	VB	be vbi NUPOS
derived	VBN	derive VBN PennPOS
by	IN	by IN PennPOS
activation/proliferation	NN	activation/proliferation NN PennPOS
of	IN	of pp-f NUPOS
resident	JJ	resident JJ PennPOS
lung	NN	lung NN PennPOS
fibroblasts	NNS	fibroblast NNS PennPOS
,	,	, , NUPOS
epithelial-mesenchymal	JJ	epithelial-mesenchymal JJ PennPOS
differentiation	NN	differentiation NN PennPOS
,	,	, , NUPOS
or	CC	or cc NUPOS
recruitment	NN	recruitment NN PennPOS
of	IN	of pp-f NUPOS
circulating	VBG	circulate VBG PennPOS
fibroblastic	JJ	fibroblastic JJ PennPOS
stem	NN	stem NN PennPOS
cells	NNS	cell NNS PennPOS
(	(	( ( NUPOS
fibrocytes	NNS	fibrocyte NNS PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

From	IN	from pp NUPOS
a	DT	a dt NUPOS
therapeutic	JJ	therapeutic JJ PennPOS
viewpoint	NN	viewpoint NN PennPOS
,	,	, , NUPOS
interfering	VBG	interfere VBG PennPOS
with	IN	with pp NUPOS
the	DT	the dt NUPOS
pathways	NNS	pathway n2 NUPOS
that	WDT	that WDT PennPOS
lead	VBP	lead VBP PennPOS
to	TO	to p-acp NUPOS
myofibroblast	JJ	myofibroblast JJ PennPOS
expansion	NN	expansion NN PennPOS
should	MD	shall vmd NUPOS
be	VB	be vbi NUPOS
of	IN	of pp-f NUPOS
considerable	JJ	considerable JJ PennPOS
benefit	NN	benefit NN PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
treatment	NN	treatment NN PennPOS
of	IN	of pp-f NUPOS
IPF	NN	IPF NN PennPOS
.	.	. . NUPOS

This	DT	this d NUPOS
review	NN	review NN PennPOS
will	MD	will vmb NUPOS
highlight	VB	highlight VBP PennPOS
some	DT	some d NUPOS
of	IN	of pp-f NUPOS
the	DT	the dt NUPOS
key	JJ	key JJ PennPOS
molecules	NNS	molecule NNS PennPOS
involved	VBN	involve VBN PennPOS
in	IN	in IN PennPOS
this	DT	this d NUPOS
process	NN	process NN PennPOS
and	CC	and cc NUPOS
the	DT	the dt NUPOS
clinical	JJ	clinical JJ PennPOS
trials	NNS	trial NNS PennPOS
that	WDT	that WDT PennPOS
have	VBP	have vhb NUPOS
ensued	VBN	ensue vvn NUPOS
.	.	. . NUPOS

